Mounjaro and Ozempic are often mentioned in the same breath, but they are not identical. Mounjaro's active ingredient is tirzepatide, while Ozempic's is semaglutide. That single difference changes how each one works in the body.
One receptor vs. two
Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on GLP-1 and a second receptor called GIP. Many people describe the dual action as producing stronger appetite changes, though individual results vary and neither is a guarantee.
Approved uses differ
- Both are prescription medications that require a clinician.
- Their FDA-approved indications and dosing schedules are not the same.
- Only your prescriber can say which, if either, fits your situation.
If you are comparing options, focus less on brand names and more on the conversation with a licensed clinician about your health history, goals and tolerance for side effects.
This article is educational and is not medical advice. GLP-1 medications are prescription products. Always follow the instructions from your prescribing clinician and pharmacist, and contact them with questions about your specific situation.
See what GLP-1 medications actually cost
Get the free 2026 GLP-1 pricing report — real prices from the top providers, no fluff.
Get the Free Report